KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Fluid/function correlation using AI-based quantification versus central subfield thickness in treatment-naïve and pre-treated patients with neovascular AMD in a real-world setting.

Anna Eidenberger, Gregor S Reiter, Virginia Mares, Sophie Frank-Publig, Philipp Fuchs, Magdalena Baratsits, Markus Gumpinger, Georg Faustmann, Alexandra Miere, Catherine Creuzot-Garcher, Ulrike Scheschy, Laurent Kodjikian, Vincent Gualino, Benjamin Wolff, Stefan Sacu, Ursula Schmidt-Erfurth

Acta Ophthalmol 104(3) 305-313

PMID40965041
PMCIDPMC13058690
DOI10.1111/aos.70000
发表日期2025-09-18
入排依据:未发现恶性肿瘤人群证据。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 2 张 PMC Figure,均未识别为 KM 图:FIGURE 1:图注未提示 KM 曲线;FIGURE 2:图注未提示 KM 曲线。
摘要

摘要

PURPOSE: To investigate the association between best-corrected visual acuity (BCVA) and quantitative macular fluid volumes, compared to central subfield thickness (CST) in treatment-naïve and previously treated patients with active neovascular age-related macular degeneration (nAMD). METHODS AND ANALYSIS: Baseline data were collected from 290 eyes of 290 participants consecutively enrolled in a prospective, randomized phase III clinical trial. Intraretinal fluid (IRF), subretinal fluid (SRF) and pigment epithelial detachment (PED) volumes were quantified and localized using an MDR-certified AI algorithm (Fluid Monitor, RetInSight). Fluid volumes and CST were included in linear regression models for comparison. RESULTS: Significantly greater IRF volumes within each macular region were observed in treatment-naïve patients, whereas larger PED volumes contributed to higher CST values in pretreated patients. In both subgroups, the largest proportion of BCVA variance could be explained by measuring IRF and SRF volumes within the entire 6-mm area (adjusted R2 = 0.140 and 0.225, respectively). In pre-treated eyes, CST explained only half as much BCVA variance as the 6-mm fluid model, and the model's fit was even poorer when compared to the CST model in the treatment-naïve subgroup (adjusted R2 = 0.078 vs. 0.198). CONCLUSION: The examination of IRF and SRF volumes significantly impacts BCVA in nAMD. The weaker association of CST highlights its limitations as a parameter of disease activity. These findings emphasize the necessity of distinct fluid volume quantification as a relevant surrogate for visual function loss or benefit in nAMD, with particular emphasis on treatment duration and fluid in regions beyond the central 1-mm.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(2,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

FIGURE 1Examples of automated segmentation of IRF (red), SRF (yellow) and PED (blue) using the Fluid Monitor (version 2.5, RetInSight, Vienna, Austria). (a) 69‐year‐old treatment‐naïve patient with nAMD presenting with a BCVA of 61 letters and a CST of 580 μm. (b) 86‐year‐old pretreated patient with nAMD presenting with a BCVA of 73 letters and a CST of 602 μm. BCVA, best corrected visual acuity; CST, central subfield thickness; IRF, intraretinal fluid; nAMD, neovascular age‐related macular degeneration; PED, pigment epithelium detachment; SRF, subretinal fluid.
非 KM Figure
FIGURE 2Simple linear regression analyses assessing the association between fluid volumes in the 1‐, 3‐ and 6‐mm EDTRS‐grid circle and visual acuity, in treatment‐naïve and pre‐treated eyes combined. BCVA, best corrected visual acuity; ETDRS, early treatment diabetic retinopathy; IRF, intraretinal fluid; PED, pigment epithelium detachment; SRF, subretinal fluid.
非 KM Figure